Aug 7, 2026 06:11AM
Aug 6, 2026 06:58AM
Aug 5, 2026 05:10PM
Jul 1, 2026 07:03AM
Jun 30, 2026 08:02AM
Jun 10, 2026 08:02AM
May 7, 2026 07:08AM Akebia Therapeutics (AKBA) Misses Q1 EPS by 2c
May 4, 2026 08:04AM
Apr 14, 2026 10:59AM
Apr 6, 2026 06:53AM
Feb 26, 2026 07:06AM
Jan 12, 2026 08:02AM
Dec 2, 2025 06:43AM
Dec 1, 2025 07:07AM Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12 million
Nov 10, 2025 07:07AM
Oct 28, 2025 04:30PM
Aug 21, 2025 08:01AM
Aug 7, 2025 07:08AM
Jun 4, 2025 08:01AM
Jun 4, 2025 06:15AM
May 8, 2025 07:11AM Akebia Therapeutics (AKBA) Tops Q1 EPS by 8c
Apr 28, 2025 06:22AM
Apr 4, 2025 06:42AM
Apr 3, 2025 08:01AM
Apr 1, 2025 03:13AM
Mar 26, 2025 09:29AM
Mar 19, 2025 04:01PM
Mar 17, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)
Mar 14, 2025 09:44AM
Mar 13, 2025 07:07AM
Jan 24, 2025 06:41AM
Jan 15, 2025 06:41AM
Jan 14, 2025 11:06AM
Jan 13, 2025 08:06AM
Nov 7, 2024 07:11AM Akebia Therapeutics (AKBA) Misses Q3 EPS by 4c
Oct 22, 2024 08:03AM
Oct 11, 2024 06:37AM
Oct 10, 2024 08:02AM
Oct 8, 2024 06:49AM
Oct 7, 2024 08:05AM
Sep 6, 2024 06:55AM
Sep 5, 2024 08:05AM Akebia Therapeutics (AKBA) and U.S. Renal Care Initiate the VOICE Trial of Vafseo (vadadustat) for Patients on Dialysis
Sep 3, 2024 04:12PM
Aug 12, 2024 06:13AM
Aug 8, 2024 07:06AM
Jul 11, 2024 06:01AM
Jun 24, 2024 08:59AM

433,572 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All